Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)

    NCI seeks bioengineering innovation to enhance solutions for cancer research and care in exploratory/developmental grants.

    Browse similar grants
    Cancer Research Grants 2026Neuroscience Research Grants 2026Research Grants Due This Month
    OverviewSimilar Grants
    OverviewSimilar Grants

    Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

    Encouraging grant applications for bioengineering innovations in cancer research and healthcare to enhance quality, speed, and accessibility.

    HHS-NIH11Due Nov 16, 2026· 18d$275,000

    Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)

    NIH supports small, multidisciplinary teams using bioengineering to solve biomedical problems and advance tools, with optional trials to test functionality or performance, excluding phase III trials.

    HHS-NIH11Due Nov 5, 2026· 7d$2,500,000

    National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)

    NIH supports national biomedical imaging and bioengineering centers that develop research-driven technologies, share them with investigators, and train researchers in their use.

    HHS-NIH11Forecasted Jan 25, 2027Forecasted

    Focused Technology Research and Development (R01 Clinical Trial Not Allowed)

    Supporting projects developing innovative technologies for biomedical research, advancing current capabilities for acquiring biomedical knowledge.

    HHS-NIH11Due Nov 5, 2026· 7d

    Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

    Support for innovative research to improve cancer control through behavior modification, screening, and understanding etiologic factors, with the aim of advancing population-based cancer studies.

    HHS-NIH11Due Nov 16, 2026· 18d